Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2011-05-26

Clinical Trial Update: Evaluation of Fosmidomycin and Clindamycin in the Treatment of Acute Uncomplicated Plasmodium Falciparum Malaria [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study evaluating fosmidomycin in combination with clindamycin for acute uncomplicated Plasmodium falciparum malar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clindamycin
  • Fosmidomycin (fosmidomycin)

Snippet

Sponsor: Zentopharm GmbH | Conditions: Malaria | Phase 2 | Status: UNKNOWN